Development of a core outcome set for myocardial infarction in clinical trials of traditional Chinese medicine: a study protocol

INTRODUCTION: Myocardial infarction (MI) is the most dangerous complication in patients with coronary heart disease. In China, there is an increasing number of randomised controlled trials (RCTs) of traditional Chinese medicine (TCM) for treating MI. However, the inconsistency of outcome reporting m...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Ruijin, Zhong, Changming, Han, Songjie, He, Tianmai, Huang, Ya, Guan, Manke, Hu, Jiayuan, Li, Min, Lin, Yiyi, Chen, Jing, Shang, Hongcai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Complementary Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924774/
https://www.ncbi.nlm.nih.gov/pubmed/31796484
http://dx.doi.org/10.1136/bmjopen-2019-032256

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924774/
https://www.ncbi.nlm.nih.gov/pubmed/31796484
http://dx.doi.org/10.1136/bmjopen-2019-032256

Ejemplares similares